BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
LTH
Life Time Group Holdings, Inc.
LTH has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
LTH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Weak | |
| Healthy |
LTH's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
LTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $41.05 | -9.9% |
| Current | 25x | $45.54 | — |
| Forward | 26x | $45.54 | — |
| Fair | 35x | $65.25 | +43% |
| Expensive | 46x | $85.57 | +88% |
Historical ranges are pointers, not guarantees.
LTH has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
LTH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for LTH, with profitability improving.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
LTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.76 | -4.6% |
| Q3 2026 | $1.85 | +45% |
| Q2 2026 | $1.84 | +80% |
| Q1 2026 | $1.71 | +78% |
| Q4 2025 | $1.66 | +124% |
| Q3 2025 | $1.28 | +88% |
| Q2 2025 | $1.02 | +92% |
| Q1 2025 | $0.96 | +174% |
| Q4 2024 | $0.74 | +100% |
LTH has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
LTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $893.5M | +14% |
| Q2 2026 | $866M | +14% |
| Q1 2026 | $788.7M | +12% |
| Q4 2025 | $745.1M | +12% |
| Q3 2025 | $782.6M | +13% |
| Q2 2025 | $761.5M | +14% |
| Q1 2025 | $706M | +18% |
| Q4 2024 | $663.3M | +19% |
LTH has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +0.4 points |
| Q2 2026 | 17% | +3 points |
| Q1 2026 | 17% | +1.9 points |
| Q4 2025 | 17% | +4.3 points |
| Q3 2025 | 17% | +3.8 points |
| Q2 2025 | 14% | -1.4 points |
| Q1 2025 | 15% | +3.2 points |
| Q4 2024 | 13% | +2.6 points |
LTH has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
LTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$26.6M | -193% |
| Q2 2026 | -$53.7M | -$27.4M |
| Q1 2026 | -$61.2M | -248% |
| Q4 2025 | -$64.6M | -341% |
| Q3 2025 | $28.6M | -55% |
| Q2 2025 | -$26.3M | -201% |
| Q1 2025 | $41.4M | +$107.8M |
| Q4 2024 | $26.8M | +$62.9M |
LTH has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over LTH on leverage, with a lower net debt burden relative to earnings.
LTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.4x | Moderate |
LTH's net debt is about 1.3 years of its operating earnings (EBITDA), down from 1.8 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
LTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 80.6 | Overbought |
LTH's weekly RSI is 66 (neutral) and its Stochastic is 81 (overbought).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over LTH on valuation relative to its sector.
LTH PE vs Consumer Cyclical Sector
| Metric | LTH | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 18x | 37% above |
| PE % | 28 | 56 | 28 pts below |
LTH is trading at 25x earnings, a 37% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
LTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.7 | 6.6% above |
| 20 week MA | $42.9 | 6.3% above |
| 50 week MA | $34.7 | 31% above |
| 100 week MA | $31.5 | 45% above |
| 200 week MA | $24.8 | 84% above |
LTH has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
LTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.2 | $18.1 | +5.1% |
| 2022 | $18.1 | $12.1 | -33% |
| 2023 | $12.1 | $15.1 | +24% |
| 2024 | $15.1 | $21.9 | +45% |
| 2025 | $21.9 | $26.8 | +22% |
| 2026 YTD | $26.8 | $45.5 | +70% |
LTH has the edge over BABA on returns for 2026, with the stronger performance.